Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Past Issue Archives
Self-Assessment Questions
Review of
Clinical Signs
Clinical Review
Pediatric Rounds
Resident Grand Rounds
Article Archives
Case Reports
Clinical Practice
Pediatric Rounds
Resident Grand Rounds
Review of
Clinical Signs

Guide to Reading
Hospital Physician
Editorial Board
Information for Authors

Reprints, Permissions, & Copyright
Site Map
Self-Assessment Questions


Answer 5
  1. Increased sensitivity of peripheral tissues to insulin. Pioglitazone and rosiglitazone are the newest insulin sensitizer medications approved by the US Food and Drug Administration. They are thiazolidinediones, a class of medications that reduce insulin resistance and increase insulin sensitivity in the peripheral tissues (eg, liver, muscle). Of the other classes of drugs used to treat diabetes mellitus, sulfonylureas are the pancreas secretagogues, biguanides (eg, metformin) diminish the hepatic gluconeogenesis, and the alpha-glucosidase inhibitors (eg, acarbose) interfere with the intestinal absorption of carbohydrates.

Click here to return to the questions


Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2009, Turner White Communications
Updated 1/04/08 • kkj